All News #Library
Biotech
Integral Molecular Out-Licenses Antibody Panel Targeting SLC2A4
17 Jun 2025 //
PR NEWSWIRE
Integral Molecular`s Bispecific Antibody Enters Clinical Trial fo
06 Mar 2025 //
PR NEWSWIRE

Market Place
Sourcing Support